TrialDrug safety2009

Liver safety in patients with type 2 diabetes treated with pioglitazone: results from a 3-year, randomized, comparator-controlled study in the US.

Keith G Tolman et al.PubMed ↗Publisher ↗

No numbers read from the abstract.